Pediatric acute lymphoblastic leukemia relapse and prognosis: key predictors and therapeutic implications
BackgroundPediatric acute lymphoblastic leukemia (ALL), the most common childhood malignancy, achieves >95% 5-year survival with risk-adapted therapies. Nonetheless, 10%–15% of patients experience relapse, with post-relapse survival <50%. Challenges remain in optimizing minimal residual diseas...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2025-12-01
|
| Series: | Frontiers in Pediatrics |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fped.2025.1710578/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|